Drug Type Small molecule drug |
Synonyms Gutinib-1 |
Target |
Action antagonists |
Mechanism DDR1 antagonists(Discoidin domain receptor 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neurodegenerative Diseases | Preclinical | United States | - |